Login / Signup
Emrah Eraslan
ORCID
Publication Activity (10 Years)
Years Active: 2021-2023
Publications (10 Years): 2
Top Topics
Atrial Fibrillation
Ejection Fraction
Patient Reported Outcomes
Palliative Care
Top Venues
BMC cancer
Immunotherapy
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Volkan Aslan
,
Atiye Cenay Karabörk Kilic
,
Ahmet Özet
,
Aytuğ Üner
,
Nazan Günel
,
Ozan Yazıcı
,
Gözde Savaş
,
Ahmet Bayrak
,
Emrah Eraslan
,
Ömür Berna Çakmak Öksüzoğlu
,
Hüseyin Koray Kılıç
,
Nuriye Ozdemir
The role of spleen volume change in predicting immunotherapy response in metastatic renal cell carcinoma.
BMC cancer
23 (1) (2023)
Osman Sütçüoğlu
,
Ayşegül İlhan
,
Seher Yildiz Tacar
,
Deniz Can Guven
,
Gokhan Ucar
,
Nuri Karadurmus
,
Fatih Yildiz
,
Emrah Eraslan
,
Doğan Uncu
,
Deniz Tural
,
Aytuğ Üner
,
Nazan Günel
,
Nuriye Ozdemir
,
Saadettin Kılıçkap
,
Ömür Berna Çakmak Öksüzoğlu
,
Ahmet Özet
,
Ozan Yazıcı
Thirty-day mortality rates after immunotherapy initiation.
Immunotherapy
13 (17) (2021)